Abstract
A Post Hoc Analysis of Tolvaptan (TOL) Efficacy and Safety in Slowing Rate of Renal Function Decline in Subjects with Very Late-Stage Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have